Emmanouil, M.; Tseveleki, V.; Triantafyllakou, I.; Nteli, A.; Tselios, T.; Probert, L.
A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis. Molecules 2018, 23, 304.
https://doi.org/10.3390/molecules23020304
AMA Style
Emmanouil M, Tseveleki V, Triantafyllakou I, Nteli A, Tselios T, Probert L.
A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis. Molecules. 2018; 23(2):304.
https://doi.org/10.3390/molecules23020304
Chicago/Turabian Style
Emmanouil, Mary, Vivian Tseveleki, Iro Triantafyllakou, Agathi Nteli, Theodore Tselios, and Lesley Probert.
2018. "A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis" Molecules 23, no. 2: 304.
https://doi.org/10.3390/molecules23020304
APA Style
Emmanouil, M., Tseveleki, V., Triantafyllakou, I., Nteli, A., Tselios, T., & Probert, L.
(2018). A Cyclic Altered Peptide Analogue Based on Myelin Basic Protein 87–99 Provides Lasting Prophylactic and Therapeutic Protection Against Acute Experimental Autoimmune Encephalomyelitis. Molecules, 23(2), 304.
https://doi.org/10.3390/molecules23020304